Dicerna Pharmaceuticals, Inc.’s collaboration agreement with Alexion Pharmaceuticals, Inc.

Foley Hoag LLP advised Dicerna Pharmaceuticals, Inc. on the transaction Dicerna entered into a collaboration with Alexion Pharmaceuticals, Inc. to discover and develop RNA interference therapies…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now